Clinical features and treatment according to the self-declared race
| Variables | White (n=123) | Non-white (n=234) | p Value |
|---|---|---|---|
| Age (years)—mean±SD | 57.5±13.6 | 55.0±12.2 | 0.076 |
| Gender (male)—n (%) | 79 (64.2) | 158 (67.5) | 0.611 |
| Arterial hypertension (%) | 72 (58.5) | 156 (66.7) | 0.16 |
| Diabetes mellitus (%) | 32 (26.0) | 69 (29.5) | 0.57 |
| Dyslipidaemia (%) | 62 (50.4) | 121 (51.7) | 0.902 |
| Prior myocardial infarction (%) | 39 (31.7) | 58 (24.9) | 0.212 |
| Cerebrovascular disease (%) | 15 (12.2) | 29 (12.4) | 0.999 |
| Chronic kidney disease (%) | 29 (23.6) | 48 (20.5) | 0.594 |
| Atrial fibrillation (%) | 18 (14.6) | 27 (11.5) | 0.503 |
| Current smoking (%) | 12 (9.8) | 15 (6.4) | 0.355 |
| Aetiology (%) | |||
| Hypertensive | 19 (15.4) | 55 (23.5) | |
| Ischaemic | 38 (30.9) | 47 (20.1) | |
| Chagas disease | 16 (13.0) | 55 (23.5) | 0.024 |
| Cardiotoxicity | 14 (11.4) | 26 (11.1) | |
| Idiopathic | 24 (19.5) | 36 (15.4) | |
| Others | 12 (9.8) | 15 (6.4) | |
| BMI (kg/m2)—mean±SD | 27.7±6.2 | 27.4±5.3 | 0.691 |
| LVEF (%)—mean±SD | 32.8±8.3 | 31.3±8.7 | 0.132 |
| Functional III/IV—n (%) | 28 (22.8) | 40 (17.1) | 0.248 |
| β-blocker—n (%) | 120 (97.6) | 226 (96.6) | 0.852 |
| ACEi/ARB—n (%) | 68 (55.3) | 144 (61.8) | 0.281 |
| Education level ≤elementary school—n (%) | 74 (60.7) | 183 (78.2) | 0.001 |
| Familiar income (R$)—mean±SD | 1792.0±1327.2 | 1619.2±1095.2 | 0.194 |
Bold values are statistically significant (p<0.05).
Values expressed as mean±SD or percentage (%).
ACEI, ACE inhibitor; ARB, angiotensin II receptor blockers; BMI, body mass index; LVEF, left ventricular ejection fraction.